Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
57 hedge funds and large institutions have $1.11B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
12% more capital invested
Capital invested by funds: $989M → $1.11B (+$122M)
6% more funds holding
Funds holding: 54 → 57 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$16M |
| 2 |
Two Sigma Investments
New York
|
+$14.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$11.6M |
| 4 |
SC
Sculptor Capital
New York
|
+$6.81M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$6.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$80.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$25.8M |
| 3 |
ACM
Advent Capital Management
New York
|
-$25.7M |
| 4 |
BlackRock
New York
|
-$24.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$6.71M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Lazard Asset Management
New York
| $74K | +$71.4K | +648 | New |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| $60K | – | – | – |
|
53
UBS Group
Zurich,
Switzerland
| $47.9K | -$55.3K | -502 | -55% |
|
54
Osaic Holdings
Scottsdale,
Arizona
| $41K | -$46K | -417 | -54% |
|
55
US Bancorp
Minneapolis,
Minnesota
| $34.4K | +$33.1K | +300 | New |
|
56
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $23K | +$22K | +200 | New |
|
|
HDIM
57
Hanson & Doremus Investment Management
Burlington,
Vermont
| $15K | +$14.8K | +134 | New |
|
|
PTC
58
Private Trust Company
Cleveland,
Ohio
| $2K | – | – | – |
|
|
PA
59
Parallel Advisors
San Francisco,
California
| $574 | – | – | – |
|
|
CAM
60
Camden Asset Management
Los Angeles,
California
| – | -$4.09M | -40,000 | Closed |
|
|
BBL
61
Beck Bode LLC
Dedham,
Massachusetts
| – | -$245K | -2,424 | Closed |
|
|
MA
62
MUFG Americas
New York
| – | -$30K | -300 | Closed |
|
BSX.PRA Hedge Fund Activity: Q4 2022 in Review
57 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q4 2022, worth a combined $1.11B — up 12% from $989M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BSX.PRA positions and 4 closed out — a net gain of 4 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $16M. The largest seller was Russell Investments Group, cutting an estimated $80.1M.
- 57 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q4 2022, up from 54 in Q3 2022.
- Funds reported $1.11B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q4 2022, up 12% quarter-over-quarter.
- 8 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q4 2022 and 4 closed out, a net change of +4 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q4 2022 was Fidelity Investments, an estimated $16M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q4 2022 was Russell Investments Group, an estimated $80.1M sold.
Based on aggregated 13F filings for Q4 2022.